229 related articles for article (PubMed ID: 23240156)
1. [Polymorphism of ABCB1 and ABCG2 genes encoding drug transporters and their investigation by pyrosequencing].
Dribnokhodova OP; Mironov KO; Dunaeva EA; Shipulin GA
Eksp Klin Farmakol; 2012; 75(10):29-36. PubMed ID: 23240156
[TBL] [Abstract][Full Text] [Related]
2. Association of ATP-binding cassette transporter variants with the risk of Alzheimer's disease.
Cascorbi I; Flüh C; Remmler C; Haenisch S; Faltraco F; Grumbt M; Peters M; Brenn A; Thal DR; Warzok RW; Vogelgesang S
Pharmacogenomics; 2013 Apr; 14(5):485-94. PubMed ID: 23556446
[TBL] [Abstract][Full Text] [Related]
3. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters.
Choudhuri S; Klaassen CD
Int J Toxicol; 2006; 25(4):231-59. PubMed ID: 16815813
[TBL] [Abstract][Full Text] [Related]
4. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma.
Drain S; Flannely L; Drake MB; Kettle P; Orr N; Bjourson AJ; Catherwood MA; Alexander HD
Leuk Res; 2011 Nov; 35(11):1457-63. PubMed ID: 21705081
[TBL] [Abstract][Full Text] [Related]
6. Impact of CYP2D6, CYP3A5, CYP2C19, CYP2A6, SLCO1B1, ABCB1, and ABCG2 gene polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid.
Choi HY; Bae KS; Cho SH; Ghim JL; Choe S; Jung JA; Jin SJ; Kim HS; Lim HS
Pharmacogenet Genomics; 2015 Dec; 25(12):595-608. PubMed ID: 26367500
[TBL] [Abstract][Full Text] [Related]
7. Increased oral availability and brain accumulation of the ALK inhibitor crizotinib by coadministration of the P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar.
Tang SC; Nguyen LN; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
Int J Cancer; 2014 Mar; 134(6):1484-94. PubMed ID: 24037730
[TBL] [Abstract][Full Text] [Related]
8. The role of ABC-transporter gene polymorphisms in chemotherapy induced immunosuppression, a retrospective study in childhood acute lymphoblastic leukaemia.
Erdélyi DJ; Kámory E; Zalka A; Semsei AF; Csókay B; Andrikovics H; Tordai A; Borgulya G; Magyarosy E; Galántai I; Fekete G; Falus A; Szalai C; Kovács GT
Cell Immunol; 2006 Dec; 244(2):121-4. PubMed ID: 17434155
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy.
Erdilyi DJ; Kámory E; Csókay B; Andrikovics H; Tordai A; Kiss C; Filni-Semsei A; Janszky I; Zalka A; Fekete G; Falus A; Kovács GT; Szalai C
Pharmacogenomics J; 2008 Oct; 8(5):321-7. PubMed ID: 17938643
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of small-molecule tyrosine kinase inhibitors: Optimizing the magic bullet.
Pander J; Guchelaar HJ; Gelderblom H
Curr Opin Mol Ther; 2010 Dec; 12(6):654-61. PubMed ID: 21154157
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of MDR1 and ABCG2 genetic polymorphisms with the efficacy and adverse events of irinotecan chemotherapy in patients with colorectal cancer].
Sun ZW; Wang XC; Gao J; Li J; Li YY; Dang YZ; Shen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):524-8. PubMed ID: 23801203
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium.
Martino A; Campa D; Buda G; Sainz J; García-Sanz R; Jamroziak K; Reis RM; Weinhold N; Jurado M; Ríos R; Szemraj-Rogucka Z; Marques H; Szemraj J; Stein A; Kumar R; Orciuolo E; Gemignani F; Landi S; Goldschmidt H; Petrini M; Dumontet C; Canzian F; Rossi AM
Leukemia; 2012 Jun; 26(6):1419-22. PubMed ID: 22182917
[No Abstract] [Full Text] [Related]
13. Polymorphisms in ATP-binding cassette transporter genes and interaction with diet and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study.
Kopp TI; Andersen V; Tjonneland A; Vogel U
Scand J Gastroenterol; 2015; 50(12):1469-81. PubMed ID: 26109419
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of ATP-binding cassette transporters and clinical implications.
Cascorbi I; Haenisch S
Methods Mol Biol; 2010; 596():95-121. PubMed ID: 19949922
[TBL] [Abstract][Full Text] [Related]
15. Effects of the ABCG2 and ABCB1 drug transporter polymorphisms on the pharmacokinetics of bicalutamide in humans.
Kim KA; Cha YJ; Lee HM; Joo HJ; Park JY
Clin Chim Acta; 2015 Jan; 438():7-11. PubMed ID: 25124867
[TBL] [Abstract][Full Text] [Related]
16. Transporter genes ABCG2 rs2231142 and ABCB1 rs1128503 polymorphisms and atorvastatin response in Chilean subjects.
Prado Y; Zambrano T; Salazar LA
J Clin Pharm Ther; 2018 Feb; 43(1):87-91. PubMed ID: 28833323
[TBL] [Abstract][Full Text] [Related]
17. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
18. Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta.
Neumanova Z; Cerveny L; Ceckova M; Staud F
AIDS; 2014 Jan; 28(1):9-17. PubMed ID: 24413260
[TBL] [Abstract][Full Text] [Related]
19. High plasma concentrations of dolutegravir in patients with ABCG2 genetic variants.
Tsuchiya K; Hayashida T; Hamada A; Oki S; Oka S; Gatanaga H
Pharmacogenet Genomics; 2017 Nov; 27(11):416-419. PubMed ID: 28858994
[TBL] [Abstract][Full Text] [Related]
20. Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers.
Akamine Y; Miura M; Sunagawa S; Kagaya H; Yasui-Furukori N; Uno T
Xenobiotica; 2010 Nov; 40(11):782-9. PubMed ID: 20839930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
